Jiazhen Yin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Diffusion Weighted Imaging

Chronic Kidney Disease

Top Venues

International urology and nephrology

Analytical cellular pathology (Amsterdam)

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Rihong Hu, Jiazhen Yin, Tingfei He, Yuxuan Zhu, Ye Li, Jinchi Gao, Xiaomin Ye, Lidan Hu, Yayu Li
Impact of COVID-19 Vaccination on Mortality and Clinical Outcomes in Hemodialysis Patients. Vaccines 12 (7) (2024)
Rihong Hu, Jiazhen Yin, Tingfei He, Yuxuan Zhu, Ye Li, Jinchi Gao, Xiaomin Ye, Lidan Hu, Yayu Li
Impact of COVID-19 Vaccination on Mortality and Clinical Outcomes in Hemodialysis Patients. Vaccines 12 (7) (2024)
Rihong Hu, Jiazhen Yin, Tingfei He, Yuxuan Zhu, Ye Li, Jinchi Gao, Xiaomin Ye, Lidan Hu, Yayu Li
Impact of COVID-19 Vaccination on Mortality and Clinical Outcomes in Hemodialysis Patients. Vaccines 12 (7) (2024)
Jiazhen Lin, Caifeng Zhu, Feng Cui, Hua Qu, Yongsheng Zhang, Xianjie Le, Jiazhen Yin, Jiazhen Lin
Based on functional and histopathological correlations: is diffusion kurtosis imaging valuable for noninvasive assessment of renal damage in early-stage of chronic kidney disease? International urology and nephrology (2023)
Senyin Xu, Lili Ma, Jiazhen Lin, Zhengxian Zhang, Xiaoya Wang, Jiazhen Yin
Efficacy and safety of percutaneous renal biopsy performed using 18G needle versus 16G needle: a single-center retrospective study. International urology and nephrology 54 (12) (2022)
Jiazhen Yin, Dongrong Yu, Lichan Mao, Caifeng Zhu, Jin Yu
Network Pharmacology and In Vivo Experimental Validation to Uncover the Renoprotective Mechanisms of Fangji Huangqi Decoction on Nephrotic Syndrome. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Lichan Mao, Yin Ding, Dongrong Yu, Jiazhen Yin, Jin Yu
Tetrandrine Attenuates Podocyte Injury by Inhibiting TRPC6-Mediated RhoA/ROCK1 Pathway. Analytical cellular pathology (Amsterdam) 2022 (2022)